Repligen Stock Working Capital

RGEN Stock

USD 157.14 0.08 0.05%

Repligen fundamentals help investors to digest information that contributes to Repligen's financial success or failures. It also enables traders to predict the movement of Repligen Stock. The fundamental analysis module provides a way to measure Repligen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Repligen stock.

	Last Reported	Projected for Next Year
Net Working Capital	952.9 M	572.6 M
Change In Working Capital	-8.6 M	-9.1 M
Working Capital	0.00	0.00

As of the 19th of April 2024, Net Working Capital is likely to drop to about 572.6 M. In addition to that, Change In Working Capital is likely to drop to about (9.1 M).

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Repligen Company Working Capital Analysis

Repligen's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Working Capital

Current Assets

-

Current Liabilities

More About Working Capital | All Equity Analysis

Current Repligen Working Capital

952.88 M

Most of Repligen's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Repligen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Repligen Working Capital Driver Correlations

Understanding the fundamental principles of building solid financial models for Repligen is extremely important. It helps to project a fair market value of Repligen Stock properly, considering its historical fundamentals such as Working Capital. Since Repligen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Repligen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Repligen's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Accounts Payable	Short Term Debt	Short Term Investments	Common Stock	Property Plant Equipment	Long Term Debt	Current Deferred Revenue	Good Will	Intangible Assets	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.81	-0.38	0.93	0.97	0.97	0.99	0.86	0.49	0.12	0.78	0.94	0.96	0.83	0.97	0.97	0.89	0.97	0.62	-0.33	0.76	0.46	0.96	0.92	0.99
Total Stockholder Equity	0.81		0.01	0.83	0.85	0.87	0.77	0.71	0.23	-0.18	0.45	0.86	0.76	0.47	0.8	0.77	0.71	0.77	0.38	-0.13	0.47	-0.01	0.76	0.72	0.75
Net Debt	-0.38	0.01		-0.08	-0.3	-0.24	-0.46	-0.44	-0.48	0.18	-0.66	-0.09	-0.45	-0.6	-0.37	-0.41	-0.37	-0.46	-0.62	0.46	-0.58	-0.76	-0.39	-0.4	-0.49
Retained Earnings	0.93	0.83	-0.08		0.95	0.96	0.91	0.77	0.38	0.22	0.64	0.99	0.9	0.7	0.93	0.91	0.87	0.9	0.51	-0.25	0.65	0.24	0.9	0.83	0.88
Net Receivables	0.97	0.85	-0.3	0.95		0.98	0.97	0.91	0.55	0.13	0.79	0.96	0.97	0.82	0.98	0.98	0.92	0.97	0.67	-0.38	0.76	0.41	0.95	0.86	0.95
Total Liab	0.97	0.87	-0.24	0.96	0.98		0.97	0.83	0.38	0.04	0.74	0.97	0.96	0.72	0.98	0.97	0.91	0.97	0.63	-0.35	0.73	0.3	0.93	0.89	0.94
Total Current Assets	0.99	0.77	-0.46	0.91	0.97	0.97		0.87	0.51	0.07	0.84	0.92	0.99	0.84	0.98	0.99	0.93	0.99	0.71	-0.42	0.81	0.49	0.95	0.91	0.98
Accounts Payable	0.86	0.71	-0.44	0.77	0.91	0.83	0.87		0.72	0.18	0.81	0.79	0.87	0.88	0.88	0.87	0.79	0.87	0.72	-0.4	0.76	0.63	0.86	0.72	0.85
Short Term Debt	0.49	0.23	-0.48	0.38	0.55	0.38	0.51	0.72		0.47	0.57	0.4	0.55	0.81	0.48	0.49	0.45	0.5	0.41	-0.39	0.43	0.66	0.54	0.3	0.5
Short Term Investments	0.12	-0.18	0.18	0.22	0.13	0.04	0.07	0.18	0.47		0.08	0.2	0.04	0.37	0.05	0.04	0.04	0.02	-0.14	-0.08	0.01	0.37	0.18	0.02	0.09
Common Stock	0.78	0.45	-0.66	0.64	0.79	0.74	0.84	0.81	0.57	0.08		0.65	0.83	0.86	0.83	0.85	0.79	0.85	0.92	-0.57	0.92	0.7	0.84	0.8	0.79
Property Plant Equipment	0.94	0.86	-0.09	0.99	0.96	0.97	0.92	0.79	0.4	0.2	0.65		0.91	0.7	0.94	0.92	0.88	0.91	0.51	-0.28	0.65	0.23	0.91	0.84	0.9
Long Term Debt	0.96	0.76	-0.45	0.9	0.97	0.96	0.99	0.87	0.55	0.04	0.83	0.91		0.83	0.98	0.98	0.96	0.99	0.73	-0.41	0.83	0.45	0.93	0.86	0.95
Current Deferred Revenue	0.83	0.47	-0.6	0.7	0.82	0.72	0.84	0.88	0.81	0.37	0.86	0.7	0.83		0.8	0.81	0.74	0.82	0.67	-0.35	0.78	0.79	0.89	0.76	0.84
Good Will	0.97	0.8	-0.37	0.93	0.98	0.98	0.98	0.88	0.48	0.05	0.83	0.94	0.98	0.8		1.0	0.94	0.99	0.76	-0.41	0.8	0.43	0.93	0.87	0.95
Intangible Assets	0.97	0.77	-0.41	0.91	0.98	0.97	0.99	0.87	0.49	0.04	0.85	0.92	0.98	0.81	1.0		0.94	1.0	0.77	-0.42	0.81	0.45	0.93	0.88	0.96
Net Tangible Assets	0.89	0.71	-0.37	0.87	0.92	0.91	0.93	0.79	0.45	0.04	0.79	0.88	0.96	0.74	0.94	0.94		0.94	0.74	-0.41	0.86	0.36	0.86	0.79	0.88
Capital Surpluse	0.97	0.77	-0.46	0.9	0.97	0.97	0.99	0.87	0.5	0.02	0.85	0.91	0.99	0.82	0.99	1.0	0.94		0.76	-0.41	0.82	0.48	0.94	0.89	0.97
Deferred Long Term Liab	0.62	0.38	-0.62	0.51	0.67	0.63	0.71	0.72	0.41	-0.14	0.92	0.51	0.73	0.67	0.76	0.77	0.74	0.76		-0.52	0.88	0.59	0.65	0.61	0.64
Accumulated Depreciation	-0.33	-0.13	0.46	-0.25	-0.38	-0.35	-0.42	-0.4	-0.39	-0.08	-0.57	-0.28	-0.41	-0.35	-0.41	-0.42	-0.41	-0.41	-0.52		-0.42	-0.36	-0.3	-0.26	-0.34
Long Term Debt Total	0.76	0.47	-0.58	0.65	0.76	0.73	0.81	0.76	0.43	0.01	0.92	0.65	0.83	0.78	0.8	0.81	0.86	0.82	0.88	-0.42		0.61	0.81	0.78	0.77
Short Long Term Debt	0.46	-0.01	-0.76	0.24	0.41	0.3	0.49	0.63	0.66	0.37	0.7	0.23	0.45	0.79	0.43	0.45	0.36	0.48	0.59	-0.36	0.61		0.5	0.41	0.53
Net Invested Capital	0.96	0.76	-0.39	0.9	0.95	0.93	0.95	0.86	0.54	0.18	0.84	0.91	0.93	0.89	0.93	0.93	0.86	0.94	0.65	-0.3	0.81	0.5		0.95	0.94
Net Working Capital	0.92	0.72	-0.4	0.83	0.86	0.89	0.91	0.72	0.3	0.02	0.8	0.84	0.86	0.76	0.87	0.88	0.79	0.89	0.61	-0.26	0.78	0.41	0.95		0.91
Capital Stock	0.99	0.75	-0.49	0.88	0.95	0.94	0.98	0.85	0.5	0.09	0.79	0.9	0.95	0.84	0.95	0.96	0.88	0.97	0.64	-0.34	0.77	0.53	0.94	0.91

Click cells to compare fundamentals

Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.

Competition

Predict Repligen

Working Capital Over Time

Repligen Capital Surpluse

Capital Surpluse

1.87 Billion

At this time, Repligen's Capital Surpluse is very stable compared to the past year.

Based on the company's disclosures, Repligen has a Working Capital of 952.88 M. This is 123.86% higher than that of the Life Sciences Tools & Services sector and 62.17% higher than that of the Health Care industry. The working capital for all United States stocks is 35.54% higher than that of the company.

Repligen Working Capital Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Repligen's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Repligen could also be used in its relative valuation, which is a method of valuing Repligen by comparing valuation metrics of similar companies.

Repligen is currently under evaluation in working capital category among related companies.

Repligen Fundamentals

	Return On Equity	0.0214
	Return On Asset	0.0131
	Profit Margin	0.07 %
	Operating Margin	0.05 %
	Current Valuation	8.72 B
	Shares Outstanding	55.84 M
	Shares Owned By Insiders	6.59 %
	Shares Owned By Institutions	93.41 %
	Number Of Shares Shorted	4.77 M
	Price To Earning	154.58 X
	Price To Book	4.86 X
	Price To Sales	14.99 X
	Revenue	638.76 M
	Gross Profit	455.71 M
	EBITDA	131.39 M
	Net Income	41.58 M
	Cash And Equivalents	596.51 M
	Cash Per Share	10.75 X
	Total Debt	711.8 M
	Debt To Equity	0.23 %
	Current Ratio	2.30 X
	Book Value Per Share	35.35 X
	Cash Flow From Operations	113.92 M
	Short Ratio	12.26 X
	Earnings Per Share	0.74 X
	Price To Earnings To Growth	2.59 X
	Target Price	204.62
	Number Of Employees	1.78 K
	Beta	1.01
	Market Capitalization	8.77 B
	Total Asset	2.82 B
	Retained Earnings	438.85 M
	Working Capital	952.88 M
	Current Asset	103.25 M
	Current Liabilities	18.78 M
	Net Asset	2.82 B

About Repligen Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Repligen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Repligen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Repligen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

BAC	Bank of America
DD	Dupont De Nemours
F	Ford Motor
WD	Walker Dunlop
GOOG	Alphabet Inc Class C

When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:

How To Invest In Repligen

Details

Is Repligen Stock a good investment?

Details

What is Repligen's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Repligen Piotroski F Score and Repligen Altman Z Score analysis.

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

Note that the Repligen information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Repligen Stock analysis

When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.

	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.

Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.55)

Earnings Share

0.74

Revenue Per Share

11.464

Quarterly Revenue Growth

(0.17)

Return On Assets

0.0131

The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Repligen Stock Working Capital

Repligen Company Working Capital Analysis

Working Capital

Current Assets

-

Current Liabilities

Current Repligen Working Capital

Repligen Working Capital Driver Correlations

Repligen Capital Surpluse

Capital Surpluse

1.87 Billion

Repligen Working Capital Peer Comparison

Repligen Fundamentals

About Repligen Fundamental Analysis

Currently Active Assets on Macroaxis

Complementary Tools for Repligen Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY